Valuation: Elekta AB (publ)

Market Cap 18.28B 1.9B 1.66B 1.53B 1.41B 2.66B 183B 2.71B 7.18B 89.22B 7.12B 6.96B 308B P/E 2027 *
12.8x
P/E 2028 * 11.4x
Enterprise Value 21.76B 2.26B 1.97B 1.82B 1.67B 3.17B 218B 3.22B 8.55B 106B 8.48B 8.29B 367B EV / Sales 2027 *
1.25x
EV / Sales 2028 * 1.18x
Free-Float
94.03%
Yield 2027 *
5.23%
Yield 2028 * 5.77%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 31/08/2025
Director of Finance/CFO - 28/02/2026
Investor Relations Contact - 30/11/2023
Director TitleAgeSince
Director/Board Member 69 29/06/2010
Director/Board Member 70 14/09/2011
Chairman 74 02/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 1.9B
+0.25%+2.47%+29.16%+2.37% 199B
+0.97%+3.63%+5.07%-14.58% 142B
+2.48%-2.98%-22.11%+12.84% 138B
+4.05%-0.27%-56.52%-14.72% 63.97B
-0.50%-4.98%+13.97%-6.34% 50.25B
+1.18%+2.27%-23.75%-31.73% 44.33B
-0.38%+0.60%+18.48%+13.65% 38.05B
+0.12%-0.45%+29.65%+39.13% 36.81B
+2.08%-0.39%-14.58%-20.62% 28.75B
Average +1.08%-0.50%-2.29%-2.22% 82.33B
Weighted average by Cap. +1.12%+0.18%+1.19%-1.53%

Financials

2027 *2028 *
Net sales 17.35B 1.8B 1.57B 1.45B 1.33B 2.53B 173B 2.57B 6.81B 84.67B 6.76B 6.61B 292B 18.1B 1.88B 1.64B 1.52B 1.39B 2.64B 181B 2.68B 7.11B 88.36B 7.05B 6.9B 305B
Net income 1.43B 148M 129M 120M 110M 208M 14.25B 211M 560M 6.96B 556M 543M 24.03B 1.61B 167M 146M 135M 124M 234M 16.05B 238M 631M 7.84B 625M 612M 27.05B
Net Debt 3.48B 361M 316M 292M 268M 507M 34.82B 516M 1.37B 17B 1.36B 1.33B 58.7B 3B 312M 272M 252M 231M 438M 30.04B 445M 1.18B 14.67B 1.17B 1.14B 50.64B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-